Method of treating or preventing rheumatoid arthritis
US10233236B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2015 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Feb 27, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/622
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is in the field of treating or preventing rheumatoid arthritis in humans and animals. In particular, the invention relates to methods for treating or preventing rheumatoid arthritis through treatment with an antibody which specifically reacts with a citrullinated epitope present on a peptide with an amino acid sequence according to SEQ ID NO:21.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.